Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms like abdominal pain, diarrhea, and weight loss.
Guselkumab for Kids with Inflammatory Conditions
We are studying the long-term safety of guselkumab in children with ulcerative colitis, Crohn’s disease, or juvenile psoriatic arthritis. This research aims to ensure the medication is safe for young patients.
1-2 yearsConfirmation phase (III)Post-Trial Drug AccessNo PlaceboCost ReimbursementStandard MedicinesInjectionDermatologyGastroenterologyRheumatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Juvenile Psoriatic Arthritis
Juvenile psoriatic arthritis is a type of arthritis that affects children and is associated with psoriasis, causing joint pain, swelling, and stiffness.
Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon, leading to symptoms like abdominal pain and bloody diarrhea.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 2 and 17 years old?
- Are you currently pregnant, nursing, or planning to become pregnant?
- Have you taken any medications that are not allowed in this study before the first dose?
- Have you completed the dosing planned in the primary pediatric guselkumab study?
- Do you have a reliable method of contraception if you are of childbearing potential?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Assistance Publique Hopitaux De Paris
Department of Pediatric Rheumatology
Croulebarbe, France
Centre Hospitalier Universitaire De Lille
Department of Gastroenterology
Loos, France
Charite Universitaetsmedizin Berlin KöR
Campus Virchow
Berlin, Germany
Sponsor: Janssen Cilag International
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.